ACE and autoimmune disease: ACE and Ang II have been investigated concerning vascular inflammation and injury; their inhibition results in diminished inflammation, reduced recruitment of leukocytes, and less damage to vascular walls, which are critical characteristics of chronic inflammatory and autoimmune disorders, including renal tubulointerstitial injury and diabetic nephropathy 42.